Prediction of the benign and malignant nature of masses in COPD background based on Habitat-based enhanced CT radiomics modeling: A preliminary study
Technology and Health Care · 2024
DOI: 10.3233/thc-231980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology and Health Care, 2024. Verfasst von Wanzhao Zuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Tomography, X-Ray Computed, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND: It is difficult to differentiate between chronic obstructive pulmonary disease (COPD)-peripheral bronchogenic carcinoma (COPD-PBC) and inflammatory masses. OBJECTIVE: This study aims to predict COPD-PBC based on clinical data and preoperative Habitat-based enhanced CT radiomics (HECT radiomics) modeling. METHODS: A retrospective analysis was conducted on clinical imaging data of 232 cases of postoperative pathological confirmed PBC or inflammatory masses. The PBC group consisted of 82 cases, while the non-PBC group consisted of 150 cases. A training set and a testing set were established using a 7:3 ratio and a time cutoff point. In the training set, multiple models were established using clinical data and radiomics texture changes within different enhanced areas of the CT mass (HECT radiomics). The AUC values of each model were compared using Delong’s test, and the clinical net benefit of the models was tested using decision curve analysis (DCA). The models were then externally validated in the testing set, and a nomogram of predicting COPD-PBC was created. RESULTS: Univariate analysis confirmed that female gender, tumor morphology, CEA, Cyfra21-1, CT enhancement pattern, and Habitat-Radscore B/C were predictive factors for COPD-PBC (P< 0.05). The combination model based on these factors had significantly higher predictive performance [AUC: 0.894, 95% CI (0.836–0.936)] than the clinical data model [AUC: 0.758, 95% CI (0.685–0.822)] and radiomics model [AUC: 0.828, 95% CI (0.761–0.882)]. DCA also confirmed the higher clinical net benefit of the combination model, which was validated in the testing set. The nomogram developed based on the combination model helped predict COPD-PBC. CONCLUSION: The combination model based on clinical data and Habitat-based enhanced CT radiomics can help differentiate COPD-PBC, providing a new non-invasive and efficient method for its diagnosis, treatment, and clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Department of Respiratory Medicine, Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang Institute of Traditional Chinese Medicine, Xiangyang, Hubei, China.
Zitieren
APA
Zuo, W., Li, J., Zuo, M., Li, M., Zhou, S., & Cai, X. (2024). Prediction of the benign and malignant nature of masses in COPD background based on Habitat-based enhanced CT radiomics modeling: A preliminary study. Technology and Health Care. https://doi.org/10.3233/thc-231980
Vancouver
Zuo W, Li J, Zuo M, Li M, Zhou S, Cai X. Prediction of the benign and malignant nature of masses in COPD background based on Habitat-based enhanced CT radiomics modeling: A preliminary study. Technology and Health Care. 2024. doi:10.3233/thc-231980
BibTeX
@article{Zuo2024,
author = {Zuo, Wanzhao and Li, Jing and Zuo, Mingyan and Li, Miao and Zhou, Shuang and Cai, Xing},
title = {Prediction of the benign and malignant nature of masses in COPD background based on Habitat-based enhanced CT radiomics modeling: A preliminary study},
journal = {Technology and Health Care},
year = {2024},
doi = {10.3233/thc-231980}
}
EUVIMED